Tagged coronary

Concept Medical Inc. Granted 2nd 'Breakthrough Device Designation' From the FDA for Its MagicTouch PTA Sirolimus Coated Balloon, for the Treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK) Indication
Press Release

Concept Medical Inc. Granted 2nd 'Breakthrough Device Designation' From the FDA for Its MagicTouch PTA Sirolimus Coated Balloon, for the Treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK) Indication

 Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK). The first 'Breakthrough Device Designation' received by Concept Medical Inc. was on 30th April 2019 for its MagicTouch SCB, for the treatment of Coronary Artery Disease (CAD) in patients with in-stent restenosis. Read More
Concept Medical Inc. Granted 'Breakthrough Device Designation' From FDA for Its MagicTouch Sirolimus Coated Balloon
Press Release

Concept Medical Inc. Granted 'Breakthrough Device Designation' From FDA for Its MagicTouch Sirolimus Coated Balloon

 Read More
Press Release

IQ4I Published a Report on "Vascular and Non-Vascular Stents Global Market - Forecast to 2021"

 The global vascular and non-vascular market is valued at $8.3 billion in 2014. This report analyzes the stent market in terms of market revenue ($ million) for all segments. Read More
Press Release

Rising Incidence of CVD Fuelling Growth in Coronary Stents Market in India

 Netscribes, Inc. launches a report on Coronary Stents Market in India 2013 covering a market with strong growth potential. It is a part of Netscribes' Healthcare Industry Series. Read More
Press Release

Body-Mass Index A Poor Indicator of Health, Say Researchers

 South Asians were found to be particularly more likely to add visceral fat, which can lead to coronary artery disease and metabolic disorders like diabetes. Read More
Press Release

Neograft Technologies, Inc. Closes $5 Million Equity Offering

 Neograft Technologies, Inc., a medical device company developing advanced cardiac technologies for use in heart bypass procedures, announced successful completion of a $5 Million equity offering on July 29, 2011. Read More
Press Release

National Cholesterol Education Month: Increasing Awareness about Heart Disease and the Importance of Lipoprotein Testing

 Cholesterol Education Month increases awareness about the link between cholesterol and heart disease, and educates individuals about the importance of lipoprotein testing in detecting risks, as performed at the Center for Cholesterol Management. Read More